199 related articles for article (PubMed ID: 1590690)
21. Favorable interaction of beta-L(-) nucleoside analogues with clinically approved anti-HIV nucleoside analogues for the treatment of human immunodeficiency virus.
Bridges EG; Dutschman GE; Gullen EA; Cheng YC
Biochem Pharmacol; 1996 Mar; 51(6):731-6. PubMed ID: 8602867
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of replication of hepatitis B virus by cytallene in vitro.
Zhu YL; Pai SB; Liu SH; Grove KL; Jones BC; Simons C; Zemlicka J; Cheng YC
Antimicrob Agents Chemother; 1997 Aug; 41(8):1755-60. PubMed ID: 9257755
[TBL] [Abstract][Full Text] [Related]
23. Mechanism of selective inhibition of human immunodeficiency virus by ingenol triacetate.
Fujiwara M; Ijichi K; Tokuhisa K; Katsuura K; Shigeta S; Konno K; Wang GY; Uemura D; Yokota T; Baba M
Antimicrob Agents Chemother; 1996 Jan; 40(1):271-3. PubMed ID: 8787923
[TBL] [Abstract][Full Text] [Related]
24. Use of the hepatitis B virus recombinant baculovirus-HepG2 system to study the effects of (-)-beta-2',3'-dideoxy-3'-thiacytidine on replication of hepatitis B virus and accumulation of covalently closed circular DNA.
Delaney WE; Miller TG; Isom HC
Antimicrob Agents Chemother; 1999 Aug; 43(8):2017-26. PubMed ID: 10428929
[TBL] [Abstract][Full Text] [Related]
25. Perspectives on the molecular mechanism of inhibition and toxicity of nucleoside analogs that target HIV-1 reverse transcriptase.
Anderson KS
Biochim Biophys Acta; 2002 Jul; 1587(2-3):296-9. PubMed ID: 12084471
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and antiviral activity of new carbonylphosphonate 2',3'-dideoxy-3'-thiacytidine conjugates.
Charvet AS; Turin F; Faury P; Hantz O; Camplo M; Mourier N; Berthillon P; Graciet JC; Chermann JC; Trépo C
Antiviral Res; 1994 Oct; 25(2):161-8. PubMed ID: 7847877
[TBL] [Abstract][Full Text] [Related]
27. Effect of 3'-azido-3'-deoxythymidine on human immunodeficiency virus type 1 replication in human fetal brain macrophages.
Geleziunas R; Arts EJ; Boulerice F; Goldman H; Wainberg MA
Antimicrob Agents Chemother; 1993 Jun; 37(6):1305-12. PubMed ID: 8392310
[TBL] [Abstract][Full Text] [Related]
28. Anti-HIV-1 activity and cellular pharmacology of various analogs of gossypol.
Lin TS; Schinazi RF; Zhu J; Birks E; Carbone R; Si Y; Wu K; Huang L; Prusoff WH
Biochem Pharmacol; 1993 Jul; 46(2):251-5. PubMed ID: 8347147
[TBL] [Abstract][Full Text] [Related]
29. The polysulphated polyxylan Hoe/Bay-946 inhibits HIV replication on human monocytes/macrophages.
von Briesen H; Meichsner C; Andreesen R; Esser R; Schrinner E; Rübsamen-Waigmann H
Res Virol; 1990; 141(2):251-7. PubMed ID: 2345812
[TBL] [Abstract][Full Text] [Related]
30. Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme.
Back NK; Nijhuis M; Keulen W; Boucher CA; Oude Essink BO; van Kuilenburg AB; van Gennip AH; Berkhout B
EMBO J; 1996 Aug; 15(15):4040-9. PubMed ID: 8670908
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, absolute configuration, and enantioselectivity of antiretroviral effect of (R)-(-)- and (S)-(+)-cytallene. Lipase-catalyzed enantioselective acylations of (+/-)-N4-acylcytallenes.
Jones BC; Silverton JV; Simons C; Megati S; Nishimura H; Maeda Y; Mitsuya H; Zemlicka J
J Med Chem; 1995 Apr; 38(8):1397-405. PubMed ID: 7731024
[TBL] [Abstract][Full Text] [Related]
32. Specificity of HIV inhibition by modified antisense oligonucleotides.
Abramova T; Blinov V; Vlassov V; Gorn V; Zarytova V; Ivanova E; Konevets D; Plyasunova O; Pokrovsky A; Sandakhchiev L
Nucleic Acids Symp Ser; 1991; (24):283. PubMed ID: 1841341
[No Abstract] [Full Text] [Related]
33. Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event.
De Clercq E; Yamamoto N; Pauwels R; Baba M; Schols D; Nakashima H; Balzarini J; Debyser Z; Murrer BA; Schwartz D
Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5286-90. PubMed ID: 1608936
[TBL] [Abstract][Full Text] [Related]
34. The biochemical basis for the differential anti-human immunodeficiency virus activity of two cis enantiomers of 2',3'-dideoxy-3'-thiacytidine.
Skalski V; Chang CN; Dutschman G; Cheng YC
J Biol Chem; 1993 Nov; 268(31):23234-8. PubMed ID: 7693686
[TBL] [Abstract][Full Text] [Related]
35. Effect of beta-enantiomeric and racemic nucleoside analogues on mitochondrial functions in HepG2 cells. Implications for predicting drug hepatotoxicity.
Cui L; Schinazi RF; Gosselin G; Imbach JL; Chu CK; Rando RF; Revankar GR; Sommadossi JP
Biochem Pharmacol; 1996 Nov; 52(10):1577-84. PubMed ID: 8937473
[TBL] [Abstract][Full Text] [Related]
36. Relationship between antiviral activity and host toxicity: comparison of the incorporation efficiencies of 2',3'-dideoxy-5-fluoro-3'-thiacytidine-triphosphate analogs by human immunodeficiency virus type 1 reverse transcriptase and human mitochondrial DNA polymerase.
Feng JY; Murakami E; Zorca SM; Johnson AA; Johnson KA; Schinazi RF; Furman PA; Anderson KS
Antimicrob Agents Chemother; 2004 Apr; 48(4):1300-6. PubMed ID: 15047533
[TBL] [Abstract][Full Text] [Related]
37. Enantioselective enzymatic biotransformation of 2'-deoxy-3'-thiacytidine (BCH 189) monitored by capillary electrophoresis.
Rogan MM; Drake C; Goodall DM; Altria KD
Anal Biochem; 1993 Feb; 208(2):343-7. PubMed ID: 8383931
[TBL] [Abstract][Full Text] [Related]
38. Resolution of racemic carbovir and selective inhibition of human immunodeficiency virus by the (-) enantiomer.
Vince R; Brownell J
Biochem Biophys Res Commun; 1990 May; 168(3):912-6. PubMed ID: 2346492
[TBL] [Abstract][Full Text] [Related]
39. Antiviral activities and cellular toxicities of modified 2',3'-dideoxy-2',3'-didehydrocytidine analogues.
Stuyver LJ; Lostia S; Adams M; Mathew JS; Pai BS; Grier J; Tharnish PM; Choi Y; Chong Y; Choo H; Chu CK; Otto MJ; Schinazi RF
Antimicrob Agents Chemother; 2002 Dec; 46(12):3854-60. PubMed ID: 12435688
[TBL] [Abstract][Full Text] [Related]
40. Antiviral activity of 5'-O-carbonate-2',3'-dideoxy-3'-thiacytidine prodrugs against hepatitis B virus in HepG2 2.2.15 cells.
Gagey D; Ravetti S; Castro EF; Gualdesi MS; Briñon MC; Campos RH; Cavallaro LV
Int J Antimicrob Agents; 2010 Dec; 36(6):566-9. PubMed ID: 20947311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
